Click Here to return To Results

 

Susceptibility to Neuroleptic Malignant Syndrome in Parkinson's Disease Neurol 52:777-781, Ueda,M.,et al, 1999 See this aricle in Pubmed Article Abstract Central dopaminergic and possible noradrenergic activity contributes to NMS development in an elderly population of PD patients. Measuring CSF levels of monoamine metabolites may provide a means for identifying NMS susceptibility in PD patients.

Related Tags

(click to filter results - removes previous filter) neuroleptic malignant syndrome Parkinson disease risk factors

Click Here to return To Results